Berk M - Search Results

1

T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model.

Slyepchenko A, Maes M, Köhler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS, Carvalho AF. Slyepchenko A, et al. Among authors: berk m. Neurosci Biobehav Rev. 2016 May;64:83-100. doi: 10.1016/j.neubiorev.2016.02.002. Epub 2016 Feb 17. Neurosci Biobehav Rev. 2016. PMID: 26898639 Review.

2

DNA damage in rats after treatment with methylphenidate.

Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, Comim CM, Cassini C, Stertz L, Ribeiro LC, Quevedo J, Kapczinski F, Berk M, Gonçalves CA. Andreazza AC, et al. Among authors: berk m. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1282-8. doi: 10.1016/j.pnpbp.2007.05.012. Epub 2007 Jun 2. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17614179

3

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.

de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS. de Lucena D, et al. Among authors: berk m. J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry. J Clin Psychiatry. 2009. PMID: 19906345 Clinical Trial.

4

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Maes M, Galecki P, Chang YS, Berk M. Maes M, et al. Among authors: berk m. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):676-92. doi: 10.1016/j.pnpbp.2010.05.004. Epub 2010 May 12. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20471444 Review.

5

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.

Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M. Maes M, et al. Among authors: berk m. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):769-83. doi: 10.1016/j.pnpbp.2010.06.008. Epub 2010 Jun 16. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20561554 Review.

6

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS. Berk M, et al. Neurosci Biobehav Rev. 2011 Jan;35(3):804-17. doi: 10.1016/j.neubiorev.2010.10.001. Epub 2010 Oct 8. Neurosci Biobehav Rev. 2011. PMID: 20934453 Review.

7

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.

Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS. Berk M, et al. J Affect Disord. 2011 Dec;135(1-3):389-94. doi: 10.1016/j.jad.2011.06.005. Epub 2011 Jun 29. J Affect Disord. 2011. PMID: 21719110 Clinical Trial.

8

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, Fitzgerald PB, Udina M, Singh A, Moylan S, Giorlando F, Doughty C, Davey CG, Theodoros M, Berk M. Dodd S, et al. Among authors: berk m. Aust N Z J Psychiatry. 2011 Sep;45(9):712-25. doi: 10.3109/00048674.2011.595686. Aust N Z J Psychiatry. 2011. PMID: 21888608 Free PMC article. Review.

9

Depressive symptoms in first episode schizophrenia spectrum disorder.

Cotton SM, Lambert M, Schimmelmann BG, Mackinnon A, Gleeson JF, Berk M, Hides L, Chanen A, McGorry PD, Conus P. Cotton SM, et al. Among authors: berk m. Schizophr Res. 2012 Jan;134(1):20-6. doi: 10.1016/j.schres.2011.08.018. Epub 2011 Sep 19. Schizophr Res. 2012. PMID: 21937197

10

Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression.

Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Maes M, et al. Among authors: berk m. J Affect Disord. 2012 Feb;136(3):386-92. doi: 10.1016/j.jad.2011.11.016. Epub 2011 Dec 12. J Affect Disord. 2012. PMID: 22166399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,642 results

Search Page

Filters